CNA Financial Corporation
NYSE:CNAInsurance - Property & Casualty
-$0.24 today
- Market cap
- $13.12B
- Beta
- 0.32
- P/E (TTM)
- 9.2
- EPS (TTM)
- $4.91
- Dividend yield
- 8.57%
Volume 0.50M
Average 0.48M
CNA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
CNA Financial CorporationNYSE: CNA
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA dips below year-ago levels
Q3 FY2026 EBITDA of $287M fell 49.4% year over year, behind the +2.3% change in trailing-twelve-month EBITDA. Sequentially, it fell 37.3% from the prior quarter. Over 3 fiscal years it compounded at +23.2% a year.
Context
- EBITDA amounted to 12.4% of revenue in FY2025, up 2.3 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $1.37B (-24.9%) for the fiscal year ending Dec 2026, a slowdown from the +29.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $287M-37.3% QoQ
- Last fiscal yearDec 2025
- $1.83B+29.3% YoY
- LTMSep 2026
- $1.5B+2.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -49.4% | -12.9% | +36.5 pp |
| 1 year | +29.3% | -24.9% | -54.3 pp |
| 3-year CAGR | +23.2% | -1.1% | -24.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 1.83B USD
- Year-over-year change
- +29.3%
- 4-year CAGR
- +2.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.83B | +29.3% |
| FY2024 | 2024-12-31 | 1.41B | -17.9% |
| FY2023 | 2023-12-31 | 1.72B | +75.8% |
| FY2022 | 2022-12-31 | 977M | -40.0% |
| FY2021 | 2021-12-31 | 1.63B | — |
EBITDA vs competitors
How CNA compares with its peers on the latest reported figures
- CNA's LTM Sep 2026 EBITDA of $1.5B is the 5th highest of the 11 companies compared; the peer median is $1.34B.
- Its year-over-year change of +2.3% is the 9th highest of 11, against a peer median of +13.7%.
- EBITDA amounts to 9.9% of revenue for CNA, versus a peer median of 18.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $11.71B | -13.0% | +24.3% | 18.9% | |
| LTM Sep 2026 | $11.52B | +37.6% | +25.2% | 23.5% | |
| LTM Sep 2026 | $2.91B | +3.3% | — | 21.9% | |
| LTM Sep 2026 | $2.59B | -16.8% | +110.2% | 15.1% | |
| LTM Sep 2026 | $1.5B | +2.3% | +23.2% | 9.9% | |
| LTM Jun 2026 | $1.38B | +21.5% | -1.8% | 16.9% | |
| LTM Sep 2026 | $1.3B | +16.3% | +9.1% | 13.5% | |
| LTM Sep 2026 | $943.1M | +13.5% | +66.5% | 13.8% | |
| LTM Sep 2026 | $676.43M | +11.2% | +47.6% | 34.6% | |
| LTM Sep 2026 | $520.91M | +13.8% | -10.4% | 26.8% | |
| LTM Jun 2026 | $280.18M | +58.6% | +55.8% | 17.1% | |
| Peer median (excluding CNA) | $1.34B | +13.7% | +25.2% | 18.0% | |
Competitors are the stored peer set for CNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 11.55B | 11.89B | 13.13B | 14B | 14.71B |
| Cost of Revenue | 7.81B | 8.14B | 8.71B | 9.54B | 10.19B |
| Gross Profit | 3.73B | 3.75B | 4.41B | 4.46B | 4.52B |
| Gross Margin | 32.3% | 31.5% | 33.6% | 31.9% | 30.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 2.27B | 2.93B | 2.9B | 3.25B | 2.9B |
| Depreciation & Amortization | 54M | 51M | 73M | 67M | 70M |
| EBITDA | 1.63B | 977M | 1.72B | 1.41B | 1.83B |
| EBITDA Margin | 14.1% | 8.2% | 13.1% | 10.1% | 12.4% |
| Operating Income | 1.46B | 814M | 1.52B | 1.21B | 1.62B |
| Operating Margin | 12.7% | 6.8% | 11.6% | 8.7% | 11.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 113M | 112M | 127M | 133M | 135M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 1.46B | 814M | 1.52B | 1.21B | 1.62B |
| Pre-Tax Margin | 12.7% | 6.8% | 11.6% | 8.7% | 11.0% |
| Income Tax Expense | 278M | 132M | 313M | 252M | 342M |
| Net Income | 1.18B | 682M | 1.21B | 959M | 1.28B |
| Net Margin | 10.3% | 5.7% | 9.2% | 6.9% | 8.7% |
| EPS (Basic) | 4.42 | 2.51 | 4.44 | 3.53 | 4.71 |
| EPS (Diluted) | 4.41 | 2.50 | 4.43 | 3.52 | 4.69 |
| Weighted Avg Shares | 271.8M | 271.6M | 271.3M | 271.3M | 271.1M |
| Weighted Avg Shares (Diluted) | 272.8M | 272.5M | 272.2M | 272.7M | 272.3M |
CNA Financial Corporation
NYSE:CNA
Intrinsic Alpha fair value
Locked
Current Price
$48.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.